0B68 Waldman, Scott - Thomas Jefferson University - Thomas Jefferson University

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. GUCY2C ligand replacement to prevent colorectal cancer
  2. Big data transforms discoveryutilization therapeutics continuum
  3. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis
  4. Bioinnovation Enterprise: An Engine Driving Breakthrough Therapies
  5. Guanylyl cyclase C as a biomarker
  6. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  7. Clinical pharmacology & therapeutics: The next five years
  8. Companion diagnostics at the intersection of personalized medicine and healthcare delivery
  9. A novel CDX2 isoform regulates alternative splicing
  10. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  11. Managing the innovation supply chain to maximize personalized medicine
  12. Molecular insights provide the critical path to disease mitigation
  13. Selective antigen-specific CD4+ T-cell, but not CD8+ T- or B-cell, tolerance corrupts cancer immunotherapy
  14. Antiobesity pharmacotherapy: New drugs and emerging targets
  15. Policies to aid the adoption of personalized medicine
  16. GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer
  17. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer
  18. Erratum: Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter randomized trial with lineage-specified biologics (Journal of the American College of Cardiology (2013) 61 (2329-2338))
  19. Reply: The C-CURE randomized clinical trial (Cardiopoietic stem Cell therapy in heart failURE)
  20. Genetics and genomics for the prevention and treatment of cardiovascular disease: Update a scientific statement from the american heart association